公开(公告)号：US20140114278A1

公开(公告)日：2014-04-24

申请号：US14144373

申请日：2013-12-30

Applicant: DexCom, Inc.

Inventor： John Michael Dobbles ,  Apurv Ullas Kamath ,  Aarthi Mahalingam ,  James H. Brauker

IPC: A61M5/172

CPC classification number: A61M5/1723 ,  A61B5/0031 ,  A61B5/14532 ,  A61B5/14546 ,  A61M5/003 ,  A61M5/14244 ,  A61M5/14276 ,  A61M5/178 ,  A61M5/20 ,  A61M5/30 ,  A61M11/00 ,  A61M15/00 ,  A61M15/0065 ,  A61M15/0068 ,  A61M15/008 ,  A61M15/0083 ,  A61M35/00 ,  A61M2005/14296 ,  A61M2205/3569 ,  A61M2205/50 ,  A61M2205/502 ,  A61M2205/52 ,  A61M2205/581 ,  A61M2205/582 ,  A61M2205/587 ,  A61M2205/8206 ,  A61M2230/201 ,  G06F19/00 ,  G06F19/3468 ,  G16H40/63

Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.

公开(公告)号：US20140114154A1

公开(公告)日：2014-04-24

申请号：US14144424

申请日：2013-12-30

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Michael Robert Mensinger ,  Ying Li ,  Aarthi Mahalingam ,  John Michael Dobbles

IPC: A61B5/00 ,  A61B5/1486 ,  A61B5/1495 ,  A61B5/145

CPC classification number: A61B5/7221 ,  A61B5/0008 ,  A61B5/0031 ,  A61B5/01 ,  A61B5/14532 ,  A61B5/14542 ,  A61B5/14546 ,  A61B5/14865 ,  A61B5/1495 ,  A61B5/4839 ,  A61B5/6848 ,  A61B5/7264 ,  A61B5/742 ,  A61B5/743 ,  A61B5/7475 ,  A61B2560/0223 ,  A61B2560/04 ,  A61B2562/085 ,  A61M5/1723 ,  G06F19/00 ,  G06F19/3456 ,  G16H15/00 ,  G16H20/00 ,  G16H40/40 ,  G16H40/63 ,  G16H50/50 ,  Y02A90/26

Abstract: Systems and methods for processing sensor data are provided. In some embodiments, systems and methods are provided for calibration of a continuous analyte sensor. In some embodiments, systems and methods are provided for classification of a level of noise on a sensor signal. In some embodiments, systems and methods are provided for determining a rate of change for analyte concentration based on a continuous sensor signal. In some embodiments, systems and methods for alerting or alarming a patient based on prediction of glucose concentration are provided.

Abstract translation: 提供了处理传感器数据的系统和方法。 在一些实施例中，提供了用于校准连续分析物传感器的系统和方法。 在一些实施例中，提供了用于对传感器信号上的噪声水平进行分类的系统和方法。 在一些实施例中，提供了系统和方法，用于基于连续的传感器信号来确定分析物浓度的变化率。 在一些实施例中，提供了基于葡萄糖浓度的预测来提醒或警告患者的系统和方法。

公开(公告)号：US20140046148A1

公开(公告)日：2014-02-13

申请号：US14057720

申请日：2013-10-18

Applicant: DexCom, Inc.

Inventor： Peter C. Simpson ,  Robert J. Book ,  Apurv Ullas Kamath ,  Matthew D. Wightlin ,  Michael J. Estes

IPC: A61B5/145

CPC classification number: A61B5/1473 ,  A61B5/14503 ,  A61B5/1451 ,  A61B5/14517 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/14865 ,  A61B2560/0223 ,  A61B2562/0209 ,  A61B2562/043 ,  A61B2562/125 ,  B05C3/10

Abstract: Devices and methods are provided for continuous measurement of an analyte concentration. The device can include a sensor having a plurality of sensor elements, each having at least one characteristic that is different from other sensor(s) of the device. In some embodiments, the plurality of sensor elements are each tuned to measure a different range of analyte concentration, thereby providing the device with the capability of achieving a substantially consistent level of measurement accuracy across a physiologically relevant range. In other embodiments, the device includes a plurality of sensor elements each tuned to measure during different time periods after insertion or implantation, thereby providing the sensor with the capability to continuously and accurately measure analyte concentrations across a wide range of time periods. For example, a sensor system 180 is provided having a first working electrode 150 comprising a first sensor element 102 and a second working electrode 160 comprising a second sensor element 104, and a reference electrode 108 for providing a reference value for measuring the working electrode potential of the sensor elements 102, 104.

公开(公告)号：US20130321426A1

公开(公告)日：2013-12-05

申请号：US13963698

申请日：2013-08-09

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Richard C. Yang ,  Jacob S. Leach ,  Nelson Quintana

IPC: G06T11/20

CPC classification number: G06T11/206 ,  A61B5/0002 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/14865 ,  A61B5/4839 ,  A61B2560/0406 ,  A61B2560/0431 ,  A61B2560/0443 ,  A61M5/003 ,  A61M5/14244 ,  A61M5/1723 ,  A61M5/24 ,  A61M5/3129 ,  A61M5/31525 ,  A61M2205/3569 ,  A61M2205/505 ,  A61M2209/086

Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

公开(公告)号：US20130296677A1

公开(公告)日：2013-11-07

申请号：US13938103

申请日：2013-07-09

Applicant: DexCom, Inc.

Inventor： Jack Pryor ,  Apurv Ullas Kamath ,  Paul V. Goode, JR. ,  James H. Brauker

IPC: A61B5/1495 ,  A61B5/1486 ,  A61B5/145

CPC classification number: A61B5/1495 ,  A61B5/0031 ,  A61B5/14503 ,  A61B5/1451 ,  A61B5/14532 ,  A61B5/14546 ,  A61B5/1468 ,  A61B5/1473 ,  A61B5/14735 ,  A61B5/1486 ,  A61B5/14865 ,  A61B2560/0223

Abstract: Systems and methods for processing sensor analyte data are disclosed, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. The sensor can be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. Reference data resulting from benchtop testing an analyte sensor prior to its insertion can be used to provide initial calibration of the sensor data. Reference data from a short term continuous analyte sensor implanted in a user can be used to initially calibrate or update sensor data from a long term continuous analyte sensor.

公开(公告)号：US20130245401A1

公开(公告)日：2013-09-19

申请号：US13796185

申请日：2013-03-12

Applicant: DEXCOM, INC.

Inventor： Michael J. Estes ,  Stephen J. Vanslyke ,  Apurv Ullas Kamath ,  Thomas A. Peyser ,  Lucas Bohnett ,  Aarthi Mahalingam ,  Arturo Garcia ,  Peter C. Simpson ,  Anna Leigh Rack-Gomer ,  Sebastian Sebastian Bohm

IPC: A61B5/1495 ,  A61B5/145

CPC classification number: A61B5/1495 ,  A61B5/0031 ,  A61B5/14503 ,  A61B5/14532 ,  A61B5/7203 ,  A61B2560/0223 ,  A61B2562/02 ,  G01D3/022 ,  G06F19/3468

Abstract: Systems and methods for applying time-dependent algorithmic compensation functions to data output from a continuous analyte sensor. Some embodiments determine a time since sensor implantation and/or whether a newly initialized sensor has been used previously.

Abstract translation: 将时间依赖算法补偿功能应用于从连续分析物传感器输出的数据的系统和方法。 一些实施例确定了自传感器植入之后的时间和/或先前已经使用了新初始化的传感器。

公开(公告)号：US20250166254A1

公开(公告)日：2025-05-22

申请号：US19028394

申请日：2025-01-17

Applicant: DexCom, Inc.

Inventor： Apurv Ullas Kamath ,  Richard C. Yang ,  Jacob S. Leach ,  Nelson Quintana

IPC: G06T11/20 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1486 ,  A61M5/00 ,  A61M5/142 ,  A61M5/172 ,  A61M5/24 ,  A61M5/31 ,  A61M5/315

Abstract: An integrated system for the monitoring and treating diabetes is provided, including an integrated receiver/hand-held medicament injection pen, including electronics, for use with a continuous glucose sensor. In some embodiments, the receiver is configured to receive continuous glucose sensor data, to calculate a medicament therapy (e.g., via the integrated system electronics) and to automatically set a bolus dose of the integrated hand-held medicament injection pen, whereby the user can manually inject the bolus dose of medicament into the host. In some embodiments, the integrated receiver and hand-held medicament injection pen are integrally formed, while in other embodiments they are detachably connected and communicated via mutually engaging electrical contacts and/or via wireless communication.

公开(公告)号：US20250032716A1

公开(公告)日：2025-01-30

申请号：US18916031

申请日：2024-10-15

Applicant: DexCom, Inc.

Inventor： John Michael Dobbles ,  Apurv Ullas Kamath ,  Aarthi Mahalingam ,  James H. Brauker

IPC: A61M5/172 ,  A61B5/00 ,  A61B5/145 ,  A61M5/00 ,  A61M5/142 ,  A61M5/178 ,  A61M5/20 ,  A61M5/30 ,  A61M11/00 ,  A61M15/00 ,  A61M35/00 ,  G16H20/17 ,  G16H40/63

Abstract: Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated.

公开(公告)号：US12193781B2

公开(公告)日：2025-01-14

申请号：US17200000

申请日：2021-03-12

Applicant: DexCom, Inc.

Inventor： Michael Robert Mensinger ,  Esteban Cabrera, Jr. ,  Eric Cohen ,  Nathaniel David Heintzman ,  Apurv Ullas Kamath ,  Gary A. Morris ,  Andrew Attila Pal ,  Eli Reihman ,  Jorge Valdes

IPC: G16H40/67 ,  A61B5/00 ,  A61B5/145 ,  G06F21/60 ,  G06F21/62 ,  G16H10/60 ,  G16H50/30

Abstract: The present disclosure relates to systems, devices and methods for receiving biosensor data acquired by a medical device, e.g., relating to glucose concentration values, and controlling the access and distribution of that data. In some embodiments, systems and methods are disclosed for monitoring glucose levels, displaying data relating to glucose values and metabolic health information, and controlling distribution of glucose data between applications executing on a computer, such as a smart phone. In some embodiments, systems and methods are disclosed for controlling access to medical data such as continuously monitored glucose levels, synchronizing health data relating to glucose levels between multiple applications executing on a computer, and/or encrypting data.

公开(公告)号：US12171547B2

公开(公告)日：2024-12-24

申请号：US16269531

申请日：2019-02-06

Applicant: DexCom, Inc.

Inventor： Alexandra Elena Constantin ,  Scott M. Belliveau ,  Naresh C. Bhavaraju ,  Jennifer Blackwell ,  Eric Cohen ,  Basab Dattaray ,  Anna Leigh Davis ,  Rian Draeger ,  Arturo Garcia ,  John Michael Gray ,  Hari Hampapuram ,  Nathaniel David Heintzman ,  Lauren Hruby Jepson ,  Matthew Lawrence Johnson ,  Apurv Ullas Kamath ,  Katherine Yerre Koehler ,  Phil Mayou ,  Patrick Wile McBride ,  Michael Robert Mensinger ,  Sumitaka Mikami ,  Andrew Attila Pal ,  Nicholas Polytaridis ,  Philip Thomas Pupa ,  Eli Reihman ,  Peter C. Simpson ,  Tomas C. Walker ,  Daniel Justin Wiedeback ,  Subrai Girish Pai ,  Matthew T. Vogel

IPC: A61B5/145 ,  A61B5/00 ,  A61B5/01 ,  A61B5/0205 ,  A61B5/11 ,  G06N5/045 ,  G06N20/00 ,  G16H50/20 ,  G16H70/20 ,  A61B5/024 ,  A61B5/08

Abstract: Systems and methods are provided to determine a time to provide guidance to a user regarding management of a physiologic condition such as diabetes. The determination may be based upon a model or pattern. The time to deliver guidance may be calculated to be useful to a user in the management of a glucose concentration level.